Financial statements Astrazeneca Pharma Poland
Cash flow statement of Astrazeneca Pharma Poland
Company age:
Age:
23 y. 3 m. 22 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of ASTRAZENECA PHARMA POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 21 945,00 | 48 547,00 | 26 015,00 | 65 441,00 | 63 375,70 | 80 237,20 |
| Net cash flow from investing activities | -25 042,00 | -45 219,00 | -24 783,00 | -63 703,00 | -61 129,90 | -79 628,40 |
| Net cash flow from financial activities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total net cash flow | -3 097,00 | 3 328,00 | 1 232,00 | 1 738,00 | 2 245,80 | 608,80 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.